These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 17424919

  • 1. [The plasma levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in breast cancer patients].
    Lawicki S, Czygier M, Omyła J, Szmitkowski M.
    Pol Arch Med Wewn; 2006 Aug; 116(2):749-55. PubMed ID: 17424919
    [Abstract] [Full Text] [Related]

  • 2. [Plasma level of macrophage-colony stimulating factor (M-CSF) in the course of breast cancer treatment].
    Lawicki S, Omyła J, Mroczko B, Szmitkowski M, Czygier M.
    Pol Arch Med Wewn; 2004 Oct; 112(4):1181-7. PubMed ID: 15773430
    [Abstract] [Full Text] [Related]

  • 3. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
    Ławicki S, Czygier M, Omyła J, Bedkowska E, Szmitkowski M.
    Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847
    [Abstract] [Full Text] [Related]

  • 4. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
    Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M.
    Przegl Lek; 2009 Oct; 66(7):365-9. PubMed ID: 20043577
    [Abstract] [Full Text] [Related]

  • 5. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients].
    ławicki S, Czygier M, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841
    [Abstract] [Full Text] [Related]

  • 6. [The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients].
    Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M.
    Przegl Lek; 2010 Nov; 67(12):1314-8. PubMed ID: 21591359
    [Abstract] [Full Text] [Related]

  • 7. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S, Szmitkowski M, Wojtukiewicz M.
    Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
    [Abstract] [Full Text] [Related]

  • 8. Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
    Ławicki S, Głażewska EK, Sobolewska M, Będkowska GE, Szmitkowski M.
    Ann Lab Med; 2016 May; 36(3):223-9. PubMed ID: 26915610
    [Abstract] [Full Text] [Related]

  • 9. Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients.
    Mroczko B, Szmitkowski M, Okulczyk B.
    Clin Chem Lab Med; 2002 Apr; 40(4):351-5. PubMed ID: 12059074
    [Abstract] [Full Text] [Related]

  • 10. [Macrophage colony-stimulating factor (M-CSF) as a candidate for the tumor marker of breast cancer].
    Ławicki S, Mroczko B, Omyła J, Czygier M, Szmitkowski M.
    Pol Arch Med Wewn; 2003 Jun; 109(6):597-602. PubMed ID: 14582473
    [Abstract] [Full Text] [Related]

  • 11. Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer.
    Mroczko B, Szmitkowski M, Niklinski J.
    Clin Chem Lab Med; 2001 May; 39(5):374-9. PubMed ID: 11434384
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.
    Ławicki S, Będkowska GE, Wojtukiewicz M, Szmitkowski M.
    Adv Med Sci; 2013 May; 58(2):207-15. PubMed ID: 23846151
    [Abstract] [Full Text] [Related]

  • 14. [The plasma levels and diagnostic utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients].
    Lawicki S, Bedkowska E, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2008 Jul; 25(145):38-42. PubMed ID: 18839612
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Granulocyte colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) as potential tumor markers in non small cell lung cancer diagnosis.
    Bahar B, Acedil Ayc Iota B, Çoşkun U, Büyükberber S, Benekli M, Yildiz R.
    Asian Pac J Cancer Prev; 2010 Jul; 11(3):709-12. PubMed ID: 21039040
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hematopoietic growth factors in colorectal cancer patients.
    Mroczko B, Szmitkowski M, Okulczyk B.
    Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.